[Use of propanidid in bioelectrical brain activation].
The purpose of the study was evaluation of propanidid as an agent activating the bioelectric activity of the brain. Examinations were carried out in 200 patients. In patients with generalized epileptic seizures a positive result of activation trial was obtained in 92,8% of the cases. In cases of focal epilepsy, temporal or not temporal, administration of propanidid revealed or increased pathological focal activity all. Activation permitted also brain tumours to be localized more precisely. In patients with cerebraal circulatory disturbances the activating effect of propanidid was observed in 82,8% of the cases. The drug is suitable for outpatient practice and for follow-up examinations.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D001932:Brain Neoplasms / Q000175:diagnosis; D002648:Child; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000175:diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011410:Propanidid / Q000494:pharmacology*; D012890:Sleep / Q000187:drug effects
D011410:Propanidid
Zastosowanie propanididu do aktywacji czynności bioelektrycznej mózgu.